Nectar Lifesciences informs about disclosure

10 Jan 2025 Evaluate
Nectar Lifesciences has informed that the exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ingain Traders LLC, Vedanta Opportunities Fund LP, Isengard Direct PE LLC.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

21.07 0.13 (0.62%)
05-Dec-2025 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1276.55
Cipla 1521.50
Zydus Lifesciences 933.10
Lupin 2089.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×